JP2013255469A - Sorghum fermented extract - Google Patents
Sorghum fermented extract Download PDFInfo
- Publication number
- JP2013255469A JP2013255469A JP2012134318A JP2012134318A JP2013255469A JP 2013255469 A JP2013255469 A JP 2013255469A JP 2012134318 A JP2012134318 A JP 2012134318A JP 2012134318 A JP2012134318 A JP 2012134318A JP 2013255469 A JP2013255469 A JP 2013255469A
- Authority
- JP
- Japan
- Prior art keywords
- sorghum
- fermented
- fermented extract
- wheat
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
【課題】免疫賦活力が優れている糖脂質素材について、アレルギー惹起の可能性を排除する。
【解決手段】従来の糖脂質素材の製法では、指定アレルギー物質とされていた小麦を利用していたが、小麦に代わり、小麦代替穀物として知られるソルガムを利用する。これにより、糖脂質の免疫賦活作用はそのままに、アレルギー惹起の心配のない素材を提供できるようになる。
【選択図】図1
[PROBLEMS] To eliminate the possibility of allergy inducing a glycolipid material having excellent immunostimulatory power.
In a conventional method for producing a glycolipid material, wheat, which has been designated as a designated allergen, is used. Instead of wheat, sorghum known as a wheat substitute grain is used. As a result, it is possible to provide a material that does not cause allergies while maintaining the immunostimulatory action of glycolipids.
[Selection] Figure 1
Description
本発明者らは、グラム陰性細菌糖脂質が経口・経皮摂取で免疫賦活作用を持ち、病気の予防・改善、健康の維持に利用できることを明らかにした。さらに、産業上の糖脂質素材製造法として、小麦粉を炭素源としてグラム陰性細菌を培養し、培養液から糖脂質を抽出する方法を開発し、その製造法、その製造法で得られる糖脂質素材および当該糖脂質素材を配合した食品、化粧品等について特許を出願している。ところで昨今、食物アレルギーの罹患率が増加しており、小麦によるアレルギーについても、消費者やメーカーが不安視する傾向が強まっている。特に化粧品分野では、石鹸に配合した小麦の加水分解物により、それまで小麦アレルギーの症状や自覚のなかった人に小麦アレルギーが発症するケースが出ており、小麦由来成分の原料が敬遠される事態となっている。このような背景の中で、我々は、小麦代替穀物として知られるようになったホワイトソルガムに着目した。 The present inventors have clarified that gram-negative bacterial glycolipids have an immunostimulatory effect when taken orally or percutaneously, and can be used for prevention / amelioration of diseases and maintenance of health. Furthermore, as an industrial glycolipid material production method, we developed a method for cultivating gram-negative bacteria using wheat flour as a carbon source and extracting glycolipid from the culture solution, and the production method and the glycolipid material obtained by the production method Patents have been filed for foods, cosmetics, and the like containing the glycolipid material. By the way, the prevalence of food allergies is increasing recently, and consumers and manufacturers are increasingly concerned about allergies caused by wheat. In the cosmetics field in particular, wheat allergies have occurred in people who have never been symptom or aware of wheat allergies due to the wheat hydrolyzate blended in soap, and the ingredients of wheat-derived ingredients are avoided. It has become. Against this background, we focused on white sorghum, which has become known as a wheat replacement grain.
ソルガムはモロコシと呼ばれる熱帯アフリカ原産のイネ科の穀物であり、生産面積ではコムギ、イネ、トウモロコシ、オオムギに次いで世界第5位の主要な穀物である。熱帯、亜熱帯の作物で乾燥に強く、イネ、コムギなどが育たない地域でも成長する(文献:wikipedia モロコシ)。アメリカで品種改良され、ソルガムに含まれるタンニンが少ないホワイトソルガムが開発されている。小麦粉に含まれるグルテンを含まないので小麦アレルギーを持つ人でも食べられるとされている。また、ミネラル分がコメよりも豊富、ビタミンB 群が豊富、不飽和脂肪酸を小麦や玄米よりも多く含む、などの特徴を有する穀物と言われている。 Sorghum is a grain of Gramineae native to tropical Africa called sorghum, and is the fifth largest grain in the world after wheat, rice, corn and barley in terms of production area. It is a tropical and subtropical crop that is resistant to drying and grows in areas where rice, wheat, etc. do not grow (reference: wikipedia sorghum). White sorghum, which has been improved in the United States and contains less tannin, is being developed. Because it does not contain gluten contained in flour, it is said that even people with wheat allergies can eat it. In addition, it is said to be a cereal having such characteristics as richer minerals than rice, rich in B vitamins, and more unsaturated fatty acids than wheat and brown rice.
ホワイトソルガムを栄養源としてグラム陰性細菌を培養することで糖脂質素材が得られることを明らかにした。本法で製造した糖脂質素材は、従来の小麦を使って得られる糖脂質素材と比較して、免疫活性化力が優れている点で遜色がなく、その一方、アレルゲンを含まない点で進歩性がある。 It was clarified that a glycolipid material can be obtained by culturing Gram-negative bacteria using white sorghum as a nutrient source. Glycolipid material produced by this method is inferior in terms of its immune activating ability compared to glycolipid materials obtained using conventional wheat, but on the other hand, it does not contain allergens There is sex.
糖脂質は自然免疫の中心的制御細胞であるマクロファージ等に働き、異物排除促進、創傷治癒促進、アレルギー抑制作用などを示す。従って、グラム陰性菌でホワイトソルガムを発酵させたことにより得られる素材は、感染症予防効果、がん治療効果、創傷治癒促進効果、生活習慣病予防効果、抗アレルギー効果などを示す機能性食品素材として効果がある。その他に、代謝病、老化促進、がん、不妊症、認知症、アレルギー性疾患などの予防効果もある。さらに、皮膚の創傷治癒促進、皮膚炎抑制、アンチエイジング、美白効果などを示すスキンケア素材としての効果が期待できる。 Glycolipids act on macrophages and the like, which are central control cells of innate immunity, and show foreign body exclusion promotion, wound healing promotion, allergy suppression action and the like. Therefore, the material obtained by fermenting white sorghum with gram-negative bacteria is a functional food material that exhibits infection prevention effect, cancer treatment effect, wound healing promotion effect, lifestyle-related disease prevention effect, antiallergic effect, etc. As effective. In addition, it has preventive effects on metabolic diseases, aging promotion, cancer, infertility, dementia, allergic diseases and the like. Furthermore, the effect as a skin care material which shows wound healing promotion of skin, dermatitis suppression, anti-aging, whitening effect, etc. can be expected.
グラム陰性菌としては、糖脂質(リポ多糖)、ペプチドグリカン、フラジェニン、非メチル化シトシン・グアニン配列を含む遺伝子などを含むものであればすべて使用できる。とくに、食経験のある菌が安全性の点からも望ましく、大腸菌、酢酸菌、キサントモナス菌、ザイモモナス菌、パントエア菌、エンテロバクター菌などがあげられる。 Any gram-negative bacterium can be used as long as it contains a glycolipid (lipopolysaccharide), peptidoglycan, flagenin, a gene containing an unmethylated cytosine / guanine sequence, and the like. In particular, bacteria with dietary experience are desirable from the viewpoint of safety, and include Escherichia coli, acetic acid bacteria, xanthomonas bacteria, zymomonas bacteria, pantoea bacteria, enterobacter bacteria, and the like.
アレルギーを引き起こさないことが知られている穀類を栄養源としてグラム陰性細菌を培養し、免疫賦活物質を製造する。 Gram-negative bacteria are cultured using cereals known not to cause allergies as nutrient sources to produce immunostimulatory substances.
本発明の発酵及び培養方法は、ソルガムを通性嫌気性グラム陰性桿菌によって発酵させて同時に該グラム陰性桿菌を培養することを特徴とする。 The fermentation and culturing method of the present invention is characterized in that sorghum is fermented with a facultative anaerobic gram negative bacilli and the gram negative bacilli are cultured at the same time.
ホワイトソルガム発酵エキスの製造 Production of fermented white sorghum extract
1.原料
食塩、ポリペプトン、イーストエクストラクト(酵母抽出物)、グリセリン、塩化アンモニウム、リン酸第一カリウム、硫酸第一鉄、硫酸マグネシウム、硫酸アンモニウム、リン酸第二カリウム、塩化カルシウム、ホワイトソルガム、アミラーゼ、ヌクレイシン、エマゾールO-30V、KM-72、水酸化ナトリウム、硫酸、リン酸、チャコール(活性炭)、セルピュアS65(珪藻土濾過助剤)、酢酸、マックス1000
1. Ingredients Salt, Polypeptone, Yeast Extract (Yeast Extract), Glycerin, Ammonium Chloride, Ferrous Potassium Phosphate, Ferrous Sulfate, Magnesium Sulfate, Ammonium Sulfate, Dibasic Potassium Phosphate, Calcium Chloride, White Sorghum, Amylase, Nucleicin , Emazole O-30V, KM-72, Sodium hydroxide, Sulfuric acid, Phosphoric acid, Charcoal (activated charcoal), Celpure S65 (Diatomaceous earth filter aid), Acetic acid, Max 1000
2.グラム陰性細菌
パントエア・アグロメランス(Pantoea agglomerans)
2. Gram-negative bacteria Pantoea agglomerans
3.発酵培養
3L容量のジャーファーメンターに2Lの培地を入れて滅菌し、パントエア・アグロメランスの前培養液を5%加えて、30℃で、50時間培養した。培地組成は下記のとおりである。ホワイトソルガムは事前にアミラーゼで酵素処理を行って使用した。培養中、pHは6.7〜7に調整し、発泡する場合には、アンチフォームを添加した。
White Sorghum 0.5%
α-amylase 0.009%
Nucleicin 0.004%
Glycerol 6%
NH4Cl 1%
K2HPO4 0.1%
KH2PO4 0.03%
FeSO4・7H2O 0.005%
CaCl2・2H2O 0.01%
KM72 0.015%
MgSO4・7H2O 0.05%
3. Fermentation culture 2 L of a medium was placed in a 3 L jar fermenter, sterilized, 5% of a pre-culture solution of Pantoair agglomerans was added, and the mixture was cultured at 30 ° C. for 50 hours. The medium composition is as follows. White sorghum was used after being previously treated with amylase. During the cultivation, the pH was adjusted to 6.7-7, and when foaming, antifoam was added.
White Sorghum 0.5%
α-amylase 0.009%
Nucleicin 0.004%
Glycerol 6%
NH4Cl 1%
K2HPO4 0.1%
KH2PO4 0.03%
FeSO4 ・ 7H2O 0.005%
CaCl2 ・ 2H2O 0.01%
KM72 0.015%
MgSO4 ・ 7H2O 0.05%
4.糖脂質抽出
上記培養終了後、90℃20分加熱して滅菌し、同時に糖脂質を抽出した。その後、雑菌の繁殖を防ぐため酢酸にてpHを酸性にし、遠心して菌体成分を除去した。
4). Glycolipid extraction After completion of the culture, the mixture was sterilized by heating at 90 ° C. for 20 minutes, and at the same time, the glycolipid was extracted. Thereafter, the pH was acidified with acetic acid to prevent the propagation of various bacteria, and the cells were removed by centrifugation.
5.精製
上記遠心後の上澄に活性炭を加え微細残渣を吸着させて遠心除去した。遠心後の上澄はさらにセライトを加えてろ過することで、清澄にした。清澄となった溶液は、UF膜を通して濃縮した。化粧品用とする場合には、UF膜濃縮溶液にNaClとEtOHを加えて糖脂質を一旦沈殿させ、沈殿物を滅菌蒸留水に再溶解して糖脂質濃度が0.01%になるように再調整し、「ホワイトソルガム発酵エキス」(Somacy-WS001)とした。
5. Purification Activated carbon was added to the supernatant after centrifugation to adsorb fine residues and removed by centrifugation. The supernatant after centrifugation was further clarified by adding celite and filtering. The clarified solution was concentrated through a UF membrane. For cosmetic use, NaCl and EtOH are added to the UF membrane concentrated solution to temporarily precipitate the glycolipid, and the precipitate is redissolved in sterilized distilled water to readjust the glycolipid concentration to 0.01%. "White sorghum fermented extract" (Somacy-WS001).
「ホワイトソルガム発酵エキス」(Somacy-WS001)の免疫賦活活性を従来の糖脂質素材である「小麦発酵抽出物」(Somacy-CL001)と比較した。免疫賦活活性化は、マウスマクロファージ細胞株RAW264.7を同濃度の両素材で刺激し、分泌される一酸化窒素量で評価した。 The immunostimulatory activity of “White Sorghum Fermented Extract” (Somacy-WS001) was compared with “Wheat Fermented Extract” (Somacy-CL001), which is a conventional glycolipid material. Immunostimulation activation was evaluated by the amount of nitric oxide secreted by stimulating the mouse macrophage cell line RAW264.7 with both materials at the same concentration.
測定結果を、Somacy-WS001とSomacy-CL001によるRAW264.7細胞からのNO産生として、図1に示した。各サンプルの有効成分IP-PA1濃度で比較を行った。各ポイントとバーは平均値とSDを示す。試験はN=3で実施した。Somacy-WS001とSomacy-CL001は、ほぼ同様の用量依存的な亜硝酸濃度の上昇を示したことから、両者はNO産生に見られるマクロファージ活性化能に差はないといえる。 The measurement results are shown in FIG. 1 as NO production from RAW264.7 cells by Somacy-WS001 and Somacy-CL001. Comparison was made with the active ingredient IP-PA1 concentration of each sample. Each point and bar represents the mean and SD. The test was performed with N = 3. Since Somacy-WS001 and Somacy-CL001 showed almost the same dose-dependent increase in nitrite concentration, it can be said that there is no difference in macrophage activation ability seen in NO production.
ホワイトソルガム発酵エキスのアレルギー性(刺激性と感作性)を51人のパッチテストによって調べることを行った。 The allergenicity (irritation and sensitization) of the white sorghum fermented extract was examined by 51 patch tests.
1.試験物質
・ホワイトソルガム発酵エキス(Somacy-WS001)の1%水溶液
・ネガティブコントロールとして蒸留水を使用
1. 1% aqueous solution of test substance, white sorghum fermented extract (Somacy-WS001), distilled water as negative control
2.被験者情報
・エントリーした人数 53人
・試験を終了した人数 51人
・年齢 22−64歳
・性別 男性 10人
女性 43人
・人種 白人 40人
スペイン人 10人
アジア人 3人
2. Subject information ・ Number of entries 53 people ・ Number of people who completed the test 51 people ・ Age 22-64 years old ・ Gender Male 10 people
43 women and 40 races Caucasian
10 Spanish
Three asians
3.消耗品
・パッチの種類:Parke-Davis Hypoallergenic Readi Bandagesまたは同等品
・1ml容量のシリンジ(針なし)
3. Consumables / Patch type: Parke-Davis Hypoallergenic Readi Bandages or equivalent • 1 ml syringe (no needle)
4.方法
被験者は、試験施設にて背中にパッチ貼付けを行い、その後帰宅して24時間後に自分でパッチをはがす。およそ24時間後に試験施設に行き、皮膚の状態の観察を行うとともに、問題がなければ繰り返しのパッチ貼付けを行う。この手順を3週間にわたり、月、水、金曜日に行い、9回まで繰り返した(一次刺激試験)。パッチ貼付けは、0.2mlの試験物質とネガティブコントロールとしての蒸留水を閉塞用低アレルギー性のパッチにつけて、被験者の背中の肩甲骨下部分で、背中より左または右の皮膚に直接貼り付けた。9回の閉塞パッチテストの終了後、10日から14日たった時に、再度24時間の閉塞パッチを1回のみ行い、パッチをはがしてから24時間後と48時間後に皮膚の状態を観察した(感作性試験)。尚、パッチ試験中に、パッチを水に塗らしたり、直接日にさらした場合、あるいは指定日に試験施設に来なかった場合、その被験者の結果はデータから除外した。最終判定は皮膚科医が行った。
4). Method Subjects apply patches on their backs at the testing facility and then remove the patches themselves 24 hours after returning home. Approximately 24 hours later, go to the testing facility and observe the skin condition, and if there are no problems, apply the patch repeatedly. This procedure was performed for 3 weeks on Monday, Wednesday and Friday and repeated up to 9 times (primary stimulation test). For patch application, 0.2 ml of the test substance and distilled water as a negative control were applied to the hypoallergenic patch for occlusion, and applied directly to the skin on the left or right side of the back in the subscapular region of the subject's back. After 10 to 14 days after the completion of the nine occlusion patch tests, the occlusion patch for 24 hours was performed once again, and the skin condition was observed 24 and 48 hours after the patch was removed (feeling) Productivity test). During the patch test, if the patch was applied to water, exposed directly to the sun, or not coming to the testing facility on the designated date, the results of the subject were excluded from the data. The final decision was made by a dermatologist.
5.結果
51人の被験者について、試験期間中、いずれの種類の有害事象も見られなかった。すなわち試験物質は、皮膚の閉塞パッチテストを行った結果、一次刺激はなく、また感作性もないことが示された。
5. Results No adverse events of any kind were observed during the study period for 51 subjects. That is, as a result of the skin occlusion patch test, the test substance showed no primary irritation and no sensitization.
Claims (7)
The sorghum fermented extract blend according to claim 6, wherein the sorghum fermented extract blend is a pharmaceutical, veterinary drug, quasi-drug, cosmetic, food, functional food, feed, or bath preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012134318A JP6334841B2 (en) | 2012-06-13 | 2012-06-13 | Sorghum fermentation and culture method, method for producing sorghum fermented extract, and method for producing sorghum fermented extract blend |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012134318A JP6334841B2 (en) | 2012-06-13 | 2012-06-13 | Sorghum fermentation and culture method, method for producing sorghum fermented extract, and method for producing sorghum fermented extract blend |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013255469A true JP2013255469A (en) | 2013-12-26 |
JP6334841B2 JP6334841B2 (en) | 2018-05-30 |
Family
ID=49952512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012134318A Active JP6334841B2 (en) | 2012-06-13 | 2012-06-13 | Sorghum fermentation and culture method, method for producing sorghum fermented extract, and method for producing sorghum fermented extract blend |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6334841B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107303255A (en) * | 2016-04-21 | 2017-10-31 | 有限公司丹鼎生物 | Sorghum fermented product with anti-inflammatory, anti-allergic and atopic skin-improving effects, preparation method and cosmetic composition thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004337095A (en) * | 2003-05-16 | 2004-12-02 | Ishibashi Kogyo Kk | Noodle and method for producing the same |
WO2005030938A1 (en) * | 2003-09-26 | 2005-04-07 | Biomedical Research Group Inc. | Fermentation and culture method, fermented plant extract, fermented plant extract powder and composition containing the fermented plant extract |
JP2007202524A (en) * | 2006-02-06 | 2007-08-16 | Nisshin Seifun Group Inc | Food material |
JP2007254338A (en) * | 2006-03-22 | 2007-10-04 | Ehime Univ | Physiologically active substance, immunomodulating active agent, allergy suppressing active agent, anticancer active agent, active oxygen scavenging active agent, food, beverage, supplement and pharmaceutical using the same |
JP2010116391A (en) * | 2008-10-17 | 2010-05-27 | Nakano Sangyo Kk | Physiologically active substance, and allergy control activator, immunomodulating activator, food and drink, supplement, and medicine containing the same |
-
2012
- 2012-06-13 JP JP2012134318A patent/JP6334841B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004337095A (en) * | 2003-05-16 | 2004-12-02 | Ishibashi Kogyo Kk | Noodle and method for producing the same |
WO2005030938A1 (en) * | 2003-09-26 | 2005-04-07 | Biomedical Research Group Inc. | Fermentation and culture method, fermented plant extract, fermented plant extract powder and composition containing the fermented plant extract |
JP2007202524A (en) * | 2006-02-06 | 2007-08-16 | Nisshin Seifun Group Inc | Food material |
JP2007254338A (en) * | 2006-03-22 | 2007-10-04 | Ehime Univ | Physiologically active substance, immunomodulating active agent, allergy suppressing active agent, anticancer active agent, active oxygen scavenging active agent, food, beverage, supplement and pharmaceutical using the same |
JP2010116391A (en) * | 2008-10-17 | 2010-05-27 | Nakano Sangyo Kk | Physiologically active substance, and allergy control activator, immunomodulating activator, food and drink, supplement, and medicine containing the same |
Non-Patent Citations (7)
Title |
---|
APPL. ENVIRON. MICROBIOL., vol. 57, no. 9, JPN6016003959, September 1991 (1991-09-01), pages 2529 - 2533, ISSN: 0003249191 * |
APPL. ENVIRONMENTAL MICROBIOL., 1998年, vol. 64, no. 12, JPN6016030436, pages 4743 - 4747, ISSN: 0003376733 * |
ARCH. ORAL BIOL., vol. 39, no. 6, JPN6016003963, June 1994 (1994-06-01), pages 459 - 466, ISSN: 0003249193 * |
ETIOLOGY, vol. 77, no. 3, JPN6016003966, 1987, pages 511 - 514, ISSN: 0003249194 * |
J. APPL. MICROBIOL., vol. 86, no. 2, JPN6016003960, February 1999 (1999-02-01), pages 221 - 225, ISSN: 0003249192 * |
MICROBIOLOGY, 2009年, vol. 78, no. 6, JPN6016030437, pages 769 - 775, ISSN: 0003376734 * |
PLANT DISEASE, 2007年, vol. 91, no. 10, JPN6016030440, pages 1365, ISSN: 0003376732 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107303255A (en) * | 2016-04-21 | 2017-10-31 | 有限公司丹鼎生物 | Sorghum fermented product with anti-inflammatory, anti-allergic and atopic skin-improving effects, preparation method and cosmetic composition thereof |
CN107303255B (en) * | 2016-04-21 | 2020-07-03 | 有限公司丹鼎生物 | Sorghum fermented product with anti-inflammatory, anti-allergic and atopic skin-improving effects, preparation method and cosmetic composition thereof |
Also Published As
Publication number | Publication date |
---|---|
JP6334841B2 (en) | 2018-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4704377B2 (en) | Fermentation and culture method, plant fermented extract, plant fermented extract powder and blended plant fermented extract | |
KR101532070B1 (en) | Composition for infected scalp and damaged hair using sulfur and fermented protein and method for manufacturing the same | |
KR101132392B1 (en) | Fermented Placenta Compositin and Use Thereof | |
CN102791849A (en) | Lactic acid bacterium-containing preparation | |
KR101734960B1 (en) | Leuconostoc holzapfelii stain for preventing depilation, improving hair growth or improving sexual disfunction, and composition comprising the same | |
CN101333548A (en) | Method for preparing gamma-aminobutyric acid by Lactobacillus brevis | |
CN106172634A (en) | A kind of processing method of nutrient biscuit | |
JP2016074647A (en) | Rice fermented products by lactic acid bacteria having moisture retention effect | |
CN116077415B (en) | Ternary probiotic factor composition for regulating skin microecological balance | |
KR101615042B1 (en) | Composition for promoting lactic acid bacteria including an extract of ecklonia cava | |
JP6334841B2 (en) | Sorghum fermentation and culture method, method for producing sorghum fermented extract, and method for producing sorghum fermented extract blend | |
CN104800094A (en) | Stretch mark prevention abdomen film | |
CN104687202B (en) | A kind of manufacture method of Fructus Musae fermented beverage | |
JP6849341B2 (en) | Fermented product | |
CN117482214B (en) | Hydrolyzed casein peptide for improving insomnia of middle-aged and elderly people and preparation method and application thereof | |
CN113244140A (en) | Composition for regulating skin micro-ecological balance and application and preparation method thereof | |
CN105168092B (en) | Face cleaning composition with biological activity and moisturizing and whitening functions and preparation method thereof | |
CN101601688A (en) | One boar placental article and preparation method thereof | |
KR100487887B1 (en) | East extract relaxing premenstrual sydrome and menstrual pain, compositions containing the same, and preparation thereof | |
CN106480147A (en) | A kind of method that red koji fermentation sea-tangle hydrolyzate prepares blood pressure lowering peptide | |
CN105688210A (en) | Yolk biological protein skin repair dressing and preparation method thereof | |
CN104982762B (en) | Garlic polysaccharide tablet and preparation method thereof | |
CN112795440A (en) | Cosmetic soap containing rice germ fermentation extract and preparation method thereof | |
CN108813341A (en) | A kind of gastral compound algae face of conditioning | |
JP6332941B2 (en) | Oral composition for beauty health |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150420 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20150420 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160203 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160404 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160810 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20170208 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180312 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180427 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6334841 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S201 | Request for registration of exclusive licence |
Free format text: JAPANESE INTERMEDIATE CODE: R314201 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |